FMR LLC - FULCRUM THERAPEUTICS INC ownership

FULCRUM THERAPEUTICS INC's ticker is FULC and the CUSIP is 359616109. A total of 106 filers reported holding FULCRUM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of FULCRUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$26,530,847
+44.8%
5,975,416
+7.6%
0.00%0.0%
Q2 2023$18,327,342
-47.8%
5,553,740
-54.9%
0.00%0.0%
Q1 2023$35,091,070
-7.9%
12,312,656
+135.3%
0.00%
-50.0%
Q4 2022$38,101,518
-39.7%
5,233,725
-32.9%
0.00%
-42.9%
Q3 2022$63,147,000
+110.3%
7,805,642
+27.4%
0.01%
+133.3%
Q2 2022$30,023,000
-79.2%
6,127,231
+0.5%
0.00%
-75.0%
Q1 2022$144,182,000
+34.0%
6,096,478
+0.2%
0.01%
+50.0%
Q4 2021$107,596,000
-36.9%
6,082,317
+0.6%
0.01%
-42.9%
Q3 2021$170,523,000
+583.8%
6,044,763
+154.0%
0.01%
+600.0%
Q2 2021$24,937,000
-12.4%
2,379,481
-1.5%
0.00%0.0%
Q1 2021$28,458,000
+38.9%
2,415,731
+38.1%
0.00%0.0%
Q4 2020$20,489,000
+40.7%
1,749,736
-4.7%
0.00%
+100.0%
Q3 2020$14,561,000
-57.0%
1,836,236
-0.8%
0.00%
-75.0%
Q2 2020$33,847,000
+59.0%
1,850,552
+3.8%
0.00%
+33.3%
Q1 2020$21,282,000
-23.2%
1,782,451
+4.8%
0.00%0.0%
Q4 2019$27,706,000
+193.6%
1,700,751
+13.9%
0.00%
+200.0%
Q3 2019$9,438,0001,492,8840.00%
Other shareholders
FULCRUM THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TRV GP III, LLC 3,962,202$19,415,0007.94%
TRV GP IV, LLC 2,343,154$11,481,0007.55%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 949$193,741,0002.02%
Logos Global Management LP 1,950,000$9,555,0001.75%
COWEN AND COMPANY, LLC 2,385,885$11,691,0001.13%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,355,624$16,443,0000.62%
ACUTA CAPITAL PARTNERS, LLC 200,000$980,0000.55%
RTW INVESTMENTS, LP 3,961,194$19,410,0000.50%
Parkman Healthcare Partners LLC 262,689$1,287,0000.47%
Deep Track Capital, LP 1,000,000$4,900,0000.32%
View complete list of FULCRUM THERAPEUTICS INC shareholders